1. Home
  2. ADC vs VTRS Comparison

ADC vs VTRS Comparison

Compare ADC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADC
  • VTRS
  • Stock Information
  • Founded
  • ADC 1971
  • VTRS 1961
  • Country
  • ADC United States
  • VTRS United States
  • Employees
  • ADC N/A
  • VTRS N/A
  • Industry
  • ADC Real Estate Investment Trusts
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • ADC Real Estate
  • VTRS Health Care
  • Exchange
  • ADC Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • ADC 8.2B
  • VTRS 9.0B
  • IPO Year
  • ADC 1994
  • VTRS N/A
  • Fundamental
  • Price
  • ADC $76.24
  • VTRS $8.03
  • Analyst Decision
  • ADC Buy
  • VTRS Hold
  • Analyst Count
  • ADC 14
  • VTRS 4
  • Target Price
  • ADC $80.27
  • VTRS $10.50
  • AVG Volume (30 Days)
  • ADC 1.6M
  • VTRS 13.7M
  • Earning Date
  • ADC 04-22-2025
  • VTRS 05-08-2025
  • Dividend Yield
  • ADC 3.92%
  • VTRS 5.98%
  • EPS Growth
  • ADC 4.57
  • VTRS N/A
  • EPS
  • ADC 1.77
  • VTRS N/A
  • Revenue
  • ADC $636,802,000.00
  • VTRS $14,739,300,000.00
  • Revenue This Year
  • ADC $11.31
  • VTRS N/A
  • Revenue Next Year
  • ADC $10.71
  • VTRS $1.20
  • P/E Ratio
  • ADC $43.64
  • VTRS N/A
  • Revenue Growth
  • ADC 13.65
  • VTRS N/A
  • 52 Week Low
  • ADC $57.02
  • VTRS $6.85
  • 52 Week High
  • ADC $79.65
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • ADC 50.82
  • VTRS 46.05
  • Support Level
  • ADC $77.63
  • VTRS $7.34
  • Resistance Level
  • ADC $79.65
  • VTRS $7.70
  • Average True Range (ATR)
  • ADC 2.38
  • VTRS 0.42
  • MACD
  • ADC 0.20
  • VTRS 0.11
  • Stochastic Oscillator
  • ADC 68.04
  • VTRS 91.47

About ADC Agree Realty Corporation

Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: